FI930319A - Liposomer som ger thymusberoende hjaelp aot svaga vaccinantigener - Google Patents

Liposomer som ger thymusberoende hjaelp aot svaga vaccinantigener Download PDF

Info

Publication number
FI930319A
FI930319A FI930319A FI930319A FI930319A FI 930319 A FI930319 A FI 930319A FI 930319 A FI930319 A FI 930319A FI 930319 A FI930319 A FI 930319A FI 930319 A FI930319 A FI 930319A
Authority
FI
Finland
Prior art keywords
vaccinantigener
thymusberoende
svaga
liposomer
hjaelp
Prior art date
Application number
FI930319A
Other languages
English (en)
Other versions
FI107515B (fi
FI930319A0 (fi
Inventor
Howard R Six
Nathalie Garcon
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI930319A publication Critical patent/FI930319A/fi
Publication of FI930319A0 publication Critical patent/FI930319A0/fi
Application granted granted Critical
Publication of FI107515B publication Critical patent/FI107515B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/829Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI930319A 1990-07-27 1993-01-26 Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi FI107515B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55896090A 1990-07-27 1990-07-27
US55896090 1990-07-27
US9105231 1991-07-24
PCT/US1991/005231 WO1992002243A1 (en) 1990-07-27 1991-07-24 Liposomes that provide thymic dependent help to weak vaccine antigens

Publications (3)

Publication Number Publication Date
FI930319A true FI930319A (fi) 1993-01-26
FI930319A0 FI930319A0 (fi) 1993-01-26
FI107515B FI107515B (fi) 2001-08-31

Family

ID=24231699

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930319A FI107515B (fi) 1990-07-27 1993-01-26 Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi

Country Status (22)

Country Link
US (1) US5464630A (fi)
EP (1) EP0542923B1 (fi)
JP (1) JP3518866B2 (fi)
KR (1) KR100213851B1 (fi)
CN (1) CN1032236C (fi)
AT (1) ATE157537T1 (fi)
AU (1) AU650299B2 (fi)
CA (1) CA2088163C (fi)
DE (1) DE69127545T2 (fi)
DK (1) DK0542923T3 (fi)
ES (1) ES2106088T3 (fi)
FI (1) FI107515B (fi)
GR (1) GR3025377T3 (fi)
HK (1) HK1008304A1 (fi)
IE (1) IE912535A1 (fi)
IL (1) IL98935A (fi)
NO (1) NO311167B1 (fi)
NZ (1) NZ239072A (fi)
PT (1) PT98470B (fi)
RU (1) RU2107493C1 (fi)
WO (1) WO1992002243A1 (fi)
ZA (1) ZA915755B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
AU3541495A (en) * 1994-09-01 1996-03-22 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AUPO732997A0 (en) 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
CN102294023A (zh) * 2001-07-26 2011-12-28 奥塔戈创新公司 抗原组合物
JP2009510032A (ja) 2005-09-30 2009-03-12 リポクセン テクノロジーズ リミテッド 多糖抗原及びタンパク質アジュバントを含む多価リポソームワクチン組成物
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
ES2664325T3 (es) 2012-01-03 2018-04-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Epítopos de CTL naturales y agonistas del antígeno tumoral de MUC1
WO2015061416A2 (en) 2013-10-23 2015-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
KR20180057610A (ko) 2015-08-03 2018-05-30 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 브라큐리 결실 돌연변이체, 브라큐리 결실 돌연변이체를 인코딩하는 비-효모 벡터, 및 이들의 용도
CA3042703A1 (en) 2016-11-07 2018-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
WO2020102404A1 (en) 2018-11-14 2020-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tp5, a peptide inhibitor of aberrant and hyperactive cdk5/p25 as treatment for cancer
WO2021150713A2 (en) 2020-01-21 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs)
US20230287067A1 (en) 2020-01-21 2023-09-14 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Human immunogenic epitopes of hemo and hhla2 human endogenous retroviruses (hervs)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
ATE157537T1 (de) 1997-09-15
EP0542923A4 (fi) 1994-04-13
CA2088163C (en) 2003-06-17
CN1032236C (zh) 1996-07-10
JP3518866B2 (ja) 2004-04-12
NO930202D0 (no) 1993-01-21
AU650299B2 (en) 1994-06-16
DE69127545D1 (de) 1997-10-09
CA2088163A1 (en) 1992-01-28
KR100213851B1 (ko) 1999-08-02
US5464630A (en) 1995-11-07
IE912535A1 (en) 1992-01-29
ZA915755B (en) 1993-02-24
DK0542923T3 (da) 1997-10-13
ES2106088T3 (es) 1997-11-01
NZ239072A (en) 1997-06-24
JPH06502630A (ja) 1994-03-24
FI107515B (fi) 2001-08-31
NO930202L (no) 1993-01-21
AU8759791A (en) 1992-03-02
DE69127545T2 (de) 1998-01-08
EP0542923A1 (en) 1993-05-26
HK1008304A1 (en) 1999-05-07
GR3025377T3 (en) 1998-02-27
EP0542923B1 (en) 1997-09-03
RU2107493C1 (ru) 1998-03-27
PT98470A (pt) 1992-06-30
FI930319A0 (fi) 1993-01-26
WO1992002243A1 (en) 1992-02-20
IL98935A0 (en) 1992-07-15
PT98470B (pt) 1998-02-27
CN1059279A (zh) 1992-03-11
IL98935A (en) 1994-01-24
NO311167B1 (no) 2001-10-22

Similar Documents

Publication Publication Date Title
FI930319A (fi) Liposomer som ger thymusberoende hjaelp aot svaga vaccinantigener
FI863730A (fi) Laekemedel innehaollande klorfluorkolvaete-aerosoldrivmedelkompositioner.
IT7926118A0 (it) Prodotti citotossici formati mediante legami covalenti della catena a della ricina con un anticorpo e procedimento per laloro preparazione.
DE69311831D1 (de) Verbesserte Pendelmikrosensoren mit Kraftrückkopplung
FI890312A0 (fi) Amfiregulin: ett nytt bifunktionellt tillvaext modulerande glykoprotein.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
FI962376A0 (fi) Siittiön zonaa sitovan proteiinin autoantigeenista epitooppia vastaavasiittiön antigeeni
FI903852A0 (fi) Foerfarande foer framstaellning av ett rekombinat subenhetsvaccin mot pseudorabiesinfektion.
RU93004915A (ru) Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины
FI894700A0 (fi) I ett steg pressad kollimator.
IT1232164B (it) Emulsione insetticida trasparente
DE68923716D1 (de) Reibungsmodifizierte ölige Konzentrate mit verbesserter Stabilität.
FI903128A0 (fi) Fibervaordskompositioner innehaollande ett aminosilikonvaordmedel.
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
ATE109834T1 (de) Monoklonaler antikörper spezifisch gegen humane pankreas-phospholipase-a2.
IE792390L (en) Hepatitis be antigen.
NO174003C (no) Monoklonale menneskeantistoffer mot pseudomonas aeruginosa eksotoksin
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
IT9043522A1 (it) Pendolo circolare accelerato dal galleggiante
FI903112A0 (fi) Foerfarande foer fluidenergibehandling av fritt floedande material och apparatur foer utfoerande av detta.
IT8521014V0 (it) Gruppo percussore e detonatore con detonatore disallineabile dal percussore.
KR890016198U (ko) 엑셀레이터 페달 고정장치
KR890019108U (ko) 클러치 겸용 가속 페달
IT8729512V0 (it) Laterizio o prefabbricato in genere preintonacato caratterizzato dal presentare tutte le zone di giunzione prive di rivestimento
FI870284A0 (fi) Foerfarande foer tillvaratagande av arsen och antimon utav ett sulfidhaltigt material.